Not finding it? Sign in to also search OpenAlex live.
-
The Roman Coronagraph Community Participation Program: pre-launch reference star list and impact of reference star properties on post-processing performance2026 Space Telescopes and Instrumentation: Optical, Infrared, and Millimeter Wave conference-abstract Physics and Astronomy Adaptive optics and wavefront sensing Open access
Justin Hom, Schuyler Grace Wolff, Jessica A. Gersh-Range, Ramya M. Anche, Vanessa P. Bailey, Jean-Philippe Berger, +48 more
0citations -
Direct Observation of Solid-Phase Crystallization of an Amorphous Complex Oxide in the Transmission Electron Microscope2023 ECS Meeting Abstracts conference-abstract Materials Science Advancements in Solid Oxide Fuel Cells
Jenna L. Wardini, George Frederick Harrington, Dennis Kemp, Roger A. De Souza, William J. Bowman
0citations -
P736 Factors associated with partial Mayo Clinic Score over time in patients with Ulcerative Colitis treated with filgotinib in the phase 2b/3 SELECTION trial2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Laurent Peyrin‐Biroulet, E Louis, Tadakazu Hisamatsu, C Jamoul, Eva Santermans, K Harris, +2 more
0citations -
LB0001 EFFICACY AND SAFETY OF DEUCRAVACITINIB UP TO WEEK 16 FROM POETYK PsA-1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Philip J. Mease, Carle F. Paul, F. Behrens, Laure Gossec, Yuichiro Kaneko, +15 more
7citations -
POS0773 LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS OR PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB: LONG-TERM RESULTS FROM PHASE 2B/3 TRIALS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Irene E. van der Horst-Bruinsma, Matthew Brown, Floris A van Gaalen, Nigil Haroon, L. S. Gensler, Alexander Marten, +5 more
2citations -
OP0004 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT LONG TERM OUTCOMES (ALTO) STUDY2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Andrew Paul Cope, Marianna Jasenecova, Joana Carvalho Vasconcelos, Andrew D. Filer, K. Raza, Maria Antonietta D’Agostino, +16 more
5citations -
POS0788 BIMEKIZUMAB DEMONSTRATED SUSTAINED EFFICACY AND SAFETY ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM TWO PHASE 3 STUDIES AND THEIR OPEN-LABEL EXTENSION2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
X. Baraliakos, A. Deodhar, Désirée M F M van der Heijde, Filip E Van den Bosch, M. Magrey, Walter P. Maksymowych, +6 more
1citations -
DOP37 Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studies2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Edward V. Loftus, Christian Maaser, Silvio Danese, C Rudolph, Rob Jongen, +2 more
5citations -
LB0010 INHIBITION OF STRUCTURAL DAMAGE PROGRESSION WITH GUSELKUMAB, A SELECTIVE IL-23i, IN PARTICIPANTS WITH ACTIVE PsA: RESULTS THROUGH WEEK 24 OF THE PHASE 3b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED APEX STUDY2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Philip J. Mease, Christopher T. Ritchlin, Laura C. Coates, A. Kollmeier, Bin Zhou, Y. Jiang, +4 more
3citations -
TGF-β and PD-L1 inhibition combined with definitive chemoradiotherapy in esophageal squamous cell carcinoma: A phase II clinical trial (NCT04595149).2021 Journal of Clinical Oncology conference-abstract Medicine Esophageal Cancer Research and Treatment
Linde M. Veen, Maarten C.C.M. Hulshof, Connie R. Jiménez, Edwin P. J. G. Cuppen, Laurens Victor Beerepoot, Geert‐Jan Creemers, +9 more
2citations -
OP25 Efficacy of filgotinib in patients with Ulcerative Colitis by line of therapy in the phase 2b/3 SELECTION trial2021 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Laurent Peyrin‐Biroulet, Iris Dotan, Toshifumi Hibi∥, Virginia Taliadouros, Alessandra Faria Oortwijn, Sally Zhao, +3 more
2citations -
P0843 Efficacy by baseline disease characteristics of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn’s disease: Results at Week 12 from the phase 3 GRAVITI study
Geert D’Haens, Flávio Steinwurz, Ailsa L Hart, Wei Yong Liu, Mobolaji Olurinde, P Ngqawa, +5 more
0citations -
P0670 Efficacy of subcutaneous guselkumab induction therapy by baseline demographics and concomitant medications in participants with moderately to severely active Crohn’s disease: Results from the phase 3 GRAVITI study2025 Journal of Crohn s and Colitis conference-abstract Medicine Inflammatory Bowel Disease Open access
Ailsa L Hart, Tadakazu Hisamatsu, Flávio Steinwurz, Geert D’Haens, Wei Yong Liu, Mobolaji Olurinde, +6 more
0citations -
POS0900 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES OVER 2 YEARS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Florian Proft, Désirée M F M van der Heijde, Sergio Schwartzman, Joerg Ermann, Alexander Marten, Ute Massow, +6 more
0citations -
P1149 Guselkumab improves health-related quality of life as measured by PROMIS-29 in participants with moderately to severely active Crohn’s disease: Phase 3 GRAVITI study2025 Journal of Crohn s and Colitis conference-abstract Medicine Inflammatory Bowel Disease Open access
Bruce E. Sands, Silvio Danese, Qian Cao, Flávio Steinwurz, Jarosław Kierkuś, Chenglong Han, +5 more
0citations -
POS0920 BIMEKIZUMAB DEMONSTRATES COMPARABLE ONE-YEAR EFFICACY IN MALE AND FEMALE PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Martín Rudwaleit, Sofía Ramiro, Denis Poddubnyy, M. Magrey, Irene E. van der Horst-Bruinsma, Atul A. Deodhar, +4 more
0citations -
POS0893 EFFICACY OF SECUKINUMAB ACROSS THE AXIAL SPONDYLOARTHRITIS SPECTRUM AMONG PATIENTS GROUPED BY AGE (≥40 YEARS VS <40): A POST HOC ANALYSIS OF 6 PHASE 3 TRIALS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Sofía Ramiro, Corine Gaillez, Uta Kiltz, Lianne S. Gensler, Chaitali Babanrao Pisal, J. Braun, +1 more
0citations